Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
4(27%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_1
4
27%
Ph phase_2
3
20%
Ph not_applicable
7
47%
Ph phase_4
1
7%

Phase Distribution

4

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
4(26.7%)
Phase 2Efficacy & side effects
3(20.0%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
7(46.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(9)
Other(2)

Detailed Status

Completed9
Active, not recruiting2
Recruiting2
Suspended1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (26.7%)
Phase 23 (20.0%)
Phase 41 (6.7%)
N/A7 (46.7%)

Trials by Status

suspended17%
active_not_recruiting213%
recruiting213%
unknown17%
completed960%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT06397612Not Applicable

Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.

Active Not Recruiting
NCT06905496Phase 1

Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.

Active Not Recruiting
NCT04074616Not Applicable

Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation

Completed
NCT06214338Not Applicable

Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

Completed
NCT05158413Not Applicable

High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety

Recruiting
NCT06264622Not Applicable

ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension

Recruiting
NCT05178667Not Applicable

Food Supplement Effect on Overweight or Moderate Obesity

Completed
NCT05485818Phase 2

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Completed
NCT05235360Not Applicable

Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention

Unknown
NCT02493712Phase 2

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Completed
NCT04439695Phase 1

Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

Completed
NCT01601093Phase 2

Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

Suspended
NCT02980250Phase 4

Multi-Center Study of Different Doses Domperidone in Feeding Intolerance

Completed
NCT00549523Phase 1

A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults

Completed
NCT01371006Phase 1

Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers

Completed

All 15 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
15